Lack of HER-2/neu Overexpression in Non-Hodgkin's Lymphoma

Objectives: The HER-2/neu oncogene is overexpressed in many types of cancer and especially in 25% to 30% of breast cancers. Single reports mention HER-2/neu positivity in hematological malignancies like Hodgkins's disease and even diffuse large-cell lymphoma. Objective. To test for HER-2/neu ov...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2004-09, Vol.24 (5B), p.3233-3237
Hauptverfasser:	Lüftner, Diana, Genvresse, Isabelle, Geppert, Rita, Kaufmann, Olaf, Dietel, Manfred, Possinger, Kurt
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Biological and medical sciences Female Hematologic and hematopoietic diseases Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymph Nodes - metabolism Lymph Nodes - pathology Lymphoma, Non-Hodgkin - blood Lymphoma, Non-Hodgkin - metabolism Lymphoma, Non-Hodgkin - pathology Lymphoma, T-Cell - blood Lymphoma, T-Cell - metabolism Lymphoma, T-Cell - pathology Male Medical sciences Middle Aged Paraffin Embedding Receptor, ErbB-2 - biosynthesis Receptor, ErbB-2 - blood Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!